New vaccines against malaria are hailed as one of the most important scientific advances. The vaccines Mosquirix and R21 reduce both the prevalence and mortality of malaria.
Moderna's mRNA cancer vaccine shows a 49 percent reduction in melanoma recurrence or death.
Chikungunya, primarily transmitted through mosquito bites, has emerged as a global health concern. Over the past 15 years, there have been approximately 5 million reported cases. Now the first vaccine for chikungunya, has received FDA approval.
Malaria claims the lives of half a million children every year, but the number is dropping thanks to new vaccines.
Tuberculosis kills over 1.6 million per year. But there is hope on the horizon, with the new M72 vaccine. The first new TB vaccine in a century.
Over the last three years, a significant decrease in child deaths due to malaria was observed, owing to the world's first malaria vaccine. Now 12 African countries are to receive 18 million doses of the malaria vaccine.
The vaccine has the potential to save up to 250,000 lives annually. NmCV-5, unlike current alternatives, provides protection against five main meningococcal strains, including the dangerous emerging X strain.